HLA-DR4-Ala74β is associated with risk and poor outcome of severe aplastic anemia

Annals of Hematology

Volumn 80, Issue 2, 2001, Pages 66-71

  Kapustin, S I ^a   Popova, T I ^a   Lyshchov, A A ^b   Imyanitov, E N ^b   Blinov, M N ^a   Abdulkadyrov, K M ^a  

^a Russian Research Institute of Hematology and Transfusiology   (Russian Federation)

^b N N PETROV RESEARCH INSTITUTE OF ONCOLOGY   (Russian Federation)

Author keywords

Aplastic anemia; Gene; HLA DR antigens; Prognosis; Susceptibility

Indexed keywords

ALANINE; CYCLOSPORIN A; HLA DR2 ANTIGEN; HLA DR4 ANTIGEN; LYMPHOCYTE ANTIBODY;

ADOLESCENT; ADULT; ALLELE; ANTIGEN SPECIFICITY; APLASTIC ANEMIA; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; DISEASE SEVERITY; FEMALE; GENETIC ASSOCIATION; GENETIC CODE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; MALE; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR;

ADOLESCENT; ADULT; ANEMIA, APLASTIC; CHILD; CHILD, PRESCHOOL; DISEASE SUSCEPTIBILITY; FEMALE; GENOTYPE; HLA-DR ANTIGENS; HLA-DR4 ANTIGEN; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; OUTCOME ASSESSMENT (HEALTH CARE); RISK FACTORS;

EID: 0035112351     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002770000234     Document Type: Article

References (25)

1. HLA antigens and haplotypes in 200 patients with aplastic anemia
2. Polymorphism, recombination, and linkage disequilibrium within the HLA class II region
3. Antithoracic duct lymphocyte globulin therapy of severe aplastic anemia
4. Selection of patients for bone marrow transplantation in severe aplastic anemia
5. Increased frequency of DR2 in patients with aplastic anemia and increased DR sharing in their parents
6. HLA associations in Italian and non-Italian Caucasoid aplastic anemia patients
7. HLA-DR, DQ and DP typing using PCR amplification and immobilized probes
8. Peptide binding specificity of HLA-DR4 molecules: Correlation with rheumatoid arthritis association
9. HLA-DR frequency in Turkish aplastic anemia patients and the impact of HLA-DR2 positivity in response rate in patients receiving immunosuppressive therapy
10. HLA-DR2 frequency increase in severe aplastic anemia patients is mainly attributed to the prevalence of DR15 subtype
11. A simple salting out procedure for extracting DNA from human nucleated cells
12. Identification of a specific HLA class II haplotype strongly associated with susceptibility to cyclosporine-dependent aplastic anemia
13. Establishment of a CD4+ T-cell clone recognizing autologous hematopoietic progenitor cells from a patient with immune-mediated aplastic anemia
14. Immune mechanism of aplastic anemia
15. Recognition of altered self major histocompatibility complex molecules modulated by specific peptide interactions
16. An increased HLA-DR2 frequency is seen in aplastic anemia patients
17. Viruses and bone marrow failure
18. Does HLA-DR predict response to specific therapy in aplastic anemia?
19. Genetic analysis of amplified DNA with immobilized sequence-specific oligonucleotide probes
20. The importance of DR4Dw4 beta chain residues 70, 71, and 86 in peptide binding and T cell recognition
21. Treatment of severe aplastic anemia
22. HLA and disease associations: Detecting the strongest association
23. Etiological mechanisms in immune-mediated aplastic anemia
24. HLA-encoded genetic predisposition in IDDM: DR4 subtypes may be associated with different degrees of protection
25. The pathophysiology of acquired aplastic anemia